Abbott plans to separate nutrition business into independent public company
Bitget2026/10/21 12:09- Abbott plans to separate its global Nutrition business into an independent, publicly traded company by the end of 2027.
- The new company will have approximately $8.5 billion in annual sales, with brands including Similac, Ensure and other nutrition products.
- Shares in the Nutrition company will be distributed to existing shareholders, who will retain ownership in both companies.
- Daniel Salvadori will lead the Nutrition company as chief executive officer.
- The remaining business will have approximately $42 billion in sales, focused on medical devices, diagnostics and established medicines.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
UBS: Raises SpaceX target price to $230
Corporate share buybacks restart, is Wall Street's biggest buyer about to hit the buy button?
The U.S. stock market's corporate buyback window is rapidly reopening as the earnings season blackout period ends. According to data from Goldman Sachs, only 12% of S&P 500 constituents are open for buybacks this week, with another 22% set to exit the blackout. Since October, buyback activity has been about 40% lower than this year's daily average. So far in 2026, buyback authorizations have reached a record $1.305 trillion, and actual buybacks in the first half of the year have increased by 15% compared to the same period last year. With limited supply of new stocks, the supply-demand balance is noticeably shifting in favor of buyback purchases, providing strong technical support for the U.S. stock market.
BUZZ—US Stock Market News—SpaceX, Elevance, Netflix
Crypto prices
More
